65347-61-7 Usage
General Description
4-(2-Methyl-3-indolyl)piperidine is a chemical compound that consists of a piperidine ring with a 2-methyl-3-indolyl group attached to the 4-position. 4-(2-METHYL-3-INDOLYL)PIPERIDINE is a derivative of piperidine, a heterocyclic amine, and indole, a bicyclic aromatic compound. It has potential biological activities, and it may be used in research for its pharmacological properties. 4-(2-METHYL-3-INDOLYL)PIPERIDINE may also have potential applications in drug discovery and development, particularly as a building block for the synthesis of novel pharmaceutical compounds. However, further studies are needed to fully understand its properties and potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 65347-61-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,3,4 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 65347-61:
(7*6)+(6*5)+(5*3)+(4*4)+(3*7)+(2*6)+(1*1)=137
137 % 10 = 7
So 65347-61-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H18N2/c1-10-14(11-6-8-15-9-7-11)12-4-2-3-5-13(12)16-10/h2-5,11,15-16H,6-9H2,1H3
65347-61-7Relevant articles and documents
INDOLE DERIVATIVES USEFUL AS HISTAMINE H3 ANTAGONISTS
-
Page 22, (2010/02/06)
Disclosed are novel compounds of the formula I wherein M1 is CH or N and M2 is C(R3) or N; R1 is optionally substituted indolyl or an aza derivative thereof; R2 is optionally substituted aryl or heteroaryl; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I in combination with a H1 receptor antagonist.